50.90
price up icon1.52%   0.76
after-market 시간 외 거래: 50.30 -0.60 -1.18%
loading

왜 Sanofi Adr (SNY) 주가가 하락하고 있습니까?

2025-09-04 거래 세션 동안 Sanofi Adr(SNY) 주식이 9.14% 하락한 것을 확인했습니다. 이는 정상적인 변동성이나 다양한 내부 및 외부 요인에 의한 것일 수 있지만, 상황을 적극적으로 모니터링하고 있으며 최대한 빨리 적시에 업데이트를 제공하도록 하겠습니다!
2023-10-27:

Sanofi ADS Stock (SNY) dropped by 19.13% from $53.33 to $43.13 in the trading on Friday October 27, 2023. The reason why SNY stock down today include

  • Third-quarter financial results. Sanofi's earnings were 2.55 euros per share, tumbled 11.5% year over year and were 2% below expectations. Sales slipped 4.1% to 11.96 billion euros, or about $12.33 billion. Analysts expected a stronger 12.48 billion euros.
  • Lower profit outlook: Sanofi expects its earnings per share to drop slightly in 2024, due to increased investment in research and development. The company has also abandoned its target of a 32% operating margin in 2025, in order to focus on long-term profitability.
  • Spinout of its consumer care unit: Sanofi is considering spinning off its consumer health unit into a separate company as early as the end of next year. The unit, which sells over-the-counter pain relievers and allergy medications like Doliprane and Allegra, accounts for just over 10% of Sanofi's total sales. The spinoff would likely be done through a listing on the Paris stock exchange.
$112.69
price up icon 1.93%
drug_manufacturers_general PFE
$27.37
price up icon 1.07%
$297.89
price up icon 0.16%
drug_manufacturers_general NVO
$59.63
price up icon 1.52%
drug_manufacturers_general MRK
$89.19
price down icon 0.36%
자본화:     |  볼륨(24시간):